Search the Newsreel

Colgate-Palmolive Lifts FY26 Adj. Earnings View, Despite Weak Q2 Profit; Stock Down

Colgate-Palmolive reported a weak Q2 profit despite higher net sales but confirmed its fiscal 2026 outlook for earnings and sales growth, while lifting guidance for Base Business earnings per share and gross profit margin. The company's shares were down approximately 2.78% in pre-market trading. …

Colgate-Palmolive falls after reporting soft organic sales in North America (CL:NYSE)

Colgate-Palmolive (CL) shares declined after its Q2 earnings report revealed a 4.9% revenue increase to $5.36 billion. However, organic sales growth was a softer 2.4%, impacted negatively by lower private label pet food sales. The report indicated some softness in North American organic sales.

MOLN Q4 2025 Earnings: Narrower Loss Than Expected Highlights Cost Discipline - Peak Earnings Alert

4D Molecular Therapeutics (NASDAQ:FDMT) Rating Increased to Strong-Buy at Chardan Capital

Meghmani Organics Q1 Results FY27: PAT Rs 48 Cr, Revenue Rs 542 Cr

Colgate-Palmolive supera estimativas de LPA, mas ações recuam - Investing.com Brasil

Colgate-Palmolive Aktie: Zahlen schlagen, Kurs fällt

Top Wall Street Forecasters Revamp Colgate-Palmolive Expectations Ahead Of Q2 Earnings

Ahead of its Q2 earnings report on Friday, July 31, Colgate-Palmolive (NYSE: CL) is expected to report quarterly earnings of 95 cents per share and revenue of $5.36 billion. Several Wall Street analysts have recently updated their ratings and price targets for the company, …

Shandong Molong Raises HK$115.7 Million Through H-Share Placement

Colgate earnings up next: Can premium products lift margins? By Investing.com

Colgate-Palmolive (CL) is set to report its second-quarter earnings, with analysts expecting $0.95 EPS and $5.36 billion in revenue. Investors will focus on the company's ability to drive margins through premium products and manage volume versus pricing dynamics, especially after a strong first quarter. …

Colgate-Palmolive (CL) Earnings on Deck: What to Watch

Colgate-Palmolive (NYSE:CL) reports second-quarter 2026 results on Friday. Let's analyze where the stock stands heading into the print. Colgate has beaten EPS estimates in each of the last four quarters, with an average beat of about 3%. The setup from last quarter Colgate's first …

Alignment Healthcare Turns Profit As Insurer Gets Handle On Costs

Alignment Healthcare reported a significant increase in its second-quarter net income, more than doubling to $36.6 million, primarily due to lower medical costs for its Medicare Advantage members. The company's medical benefit ratio improved to 86%, marking a second consecutive quarter of decline in …

Molina Healthcare Number of Employees 2026 | Employee Count & Headcount Data

Molina Healthcare, Inc. (MOH) had approximately 18,853 total employees worldwide as of March 2026, marking a 1.0% decline from 19,051 employees in 2023. Despite this, the company is actively hiring, with 1,406 active job postings in 2026, a 41.9% increase from 2025. The workforce …

Analysts Estimate Molson Coors Brewing (TAP) to Report a Decline in Earnings: What to Look Out for

The market expects Molson Coors Brewing (TAP) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that …

Colgate-Palmolive Company $CL Shares Acquired by Kentucky Retirement Systems

Kentucky Retirement Systems significantly increased its stake in Colgate-Palmolive Company (NYSE:CL) by 43.8% in the first quarter, now holding 72,567 shares valued at $6.185 million. Other institutional investors also adjusted their positions, and analysts generally maintain a "Moderate Buy" rating for the stock with …

California State Teachers Retirement System Has $108.24 Million Stock Holdings in Colgate-Palmolive Company $CL

The California State Teachers Retirement System reduced its stake in Colgate-Palmolive Company (NYSE:CL) by 2.6% in the first quarter, holding over 1.27 million shares valued at $108.24 million. Despite this, other institutional investors increased their holdings, and 80.41% of the stock is owned by …

MOLINA HEALTHCARE, INC. : WELLS FARGO CUTS TARGET PRICE TO $220 FROM $235

Wells Fargo has lowered its target price for Molina Healthcare, Inc. from $235 to $220. This adjustment in the target price suggests a revised outlook by the financial institution on the company's future performance or valuation. The article, sourced from Reuters, reports on this …

Amundi Sells 1,072,017 Shares of Colgate-Palmolive Company $CL

Amundi reduced its stake in Colgate-Palmolive Company by 17.1% during the first quarter, selling over a million shares. Despite this, other institutional investors, such as Gould Capital LLC, EverSource Wealth Advisors LLC, and Royal Bank of Canada, increased their holdings in the company. The …

4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Receives Average Rating of "Moderate Buy" from Analysts

Revenue Beat: Mold-Tek Packaging Limited Exceeded Revenue Forecasts By 5.6% And Analysts Are Updating Their Estimates

Molson Coors Beverage (TAP) to Announce Earnings on Thursday

Molina Healthcare Inc (MOH) Institutional Confidence

Molina Healthcare Inc (MOH) has an institutional shareholding score of 10.00, ranking 1st in the Healthcare Providers & Services industry. The institutional shareholding proportion is 106.83%, with a slight quarter-over-quarter decrease. David G. Herro is the largest institutional shareholder, holding 1.88% of outstanding shares.

Colgate-Palmolive Co (CL) Financial Health: Profitability & Balance Sheet Analysis

This article analyzes the financial health of Colgate-Palmolive Co (CL), noting its stable financial status and high operating efficiency. The company's current financial score is 8.12, ranking 8th in its industry. Recent quarterly results show an 8.41% year-over-year revenue increase and a 6.38% net …

CL|Colgate-Palmolive Co|Price:93.490|Chg%:+0.760

This article provides a comprehensive stock analysis of Colgate-Palmolive Co (CL), highlighting its healthy fundamentals, high growth potential, and fair valuation within the Personal & Household Products & Services industry. With strong institutional ownership and a stable stock price expected in the medium term, …

Colgate Q1 Review: Revenue Beat Prompts Target Price Hikes; Analysts Remain Divided

Colgate-Palmolive India Ltd.'s Q1 revenue exceeded expectations, leading several brokerages to increase their target prices for the stock. However, analysts remain divided due to concerns about the impact of increased brand investments and advertising spends on profit margins. While Jefferies maintained a 'Buy' rating …

Colgate-Palmolive Earnings: What To Look For From CL

Colgate-Palmolive (CL) is set to report earnings this Friday, with analysts expecting revenue growth of 4.6% year-on-year. The company previously exceeded revenue expectations last quarter, and peers like WD-40 have shown strong performance, potentially indicating positive trends for the household products segment. Investors will …

MOH5414064 Bond Risk Profile

This article provides a risk profile for the Molina Healthcare, Inc. 3.875% 15-MAY-2032 bond (MOH5414064), offering an overview of its coupon, redemption risks, and credit risk assessment metrics. It highlights key factors like security level, inflation protection, and issuer rating to help investors make …

Moleculin Biotech Files Registration Statement for Public Offering; Shares Fall

Moleculin Biotech has filed a registration statement with the SEC for a proposed public offering of its common stock and warrants, though the terms and size of the offering are yet to be determined. Following this announcement, the company's shares experienced a significant decline …

Colgate-Palmolive India Q1 profit rises 7% to ₹343 cr, sales up 12%

Colgate-Palmolive India Ltd reported a 7% increase in net profit for the June quarter of FY27, reaching ₹343.08 crore, with sales growing 12% to ₹1,590.56 crore. This growth was attributed to strong volume performance from its toothpaste portfolio and improved margins, with the gross …

ETFs Investing in Colgate-Palmolive Company Stocks

This article lists Exchange Traded Funds (ETFs) that hold Colgate-Palmolive Company (CL) stocks, providing investors with options to gain exposure to the company through diversified funds. It details various ETFs, including Vanguard, BlackRock, and State Street offerings, along with key metrics such as market …

Colgate-Palmolive India reports 12% revenue growth in Q1 FY27; net profit rises 7 per cent

Colgate-Palmolive (India) reported a 12% year-on-year increase in net sales for Q1 FY27, reaching Rs 1,591 crore, driven by strong growth across its oral care portfolio. Net profit after tax rose 7% to Rs 343 crore, with an 11% increase when excluding one-off items. …

12,424 Shares in Colgate-Palmolive Company $CL Bought by Talon Private Wealth LLC

Talon Private Wealth LLC has acquired a new stake of 12,424 shares in Colgate-Palmolive Company (NYSE:CL) during the first quarter, valued at approximately $1,059,000. This purchase is part of a broader trend where several institutional investors have either increased their holdings or initiated new …

Royal Bank of Canada Grows Stock Holdings in Colgate-Palmolive Company $CL

Royal Bank of Canada significantly increased its stake in Colgate-Palmolive by 4.4% in the first quarter, now holding 4.94 million shares valued at $421 million. This move is part of a larger trend where institutional investors own 80.41% of the company. Colgate-Palmolive (NYSE:CL) reported …

FDMT|4D Molecular Therapeutics Inc|Price:10.060|Chg%:+0.450

This analysis of 4D Molecular Therapeutics Inc (FDMT) highlights its strong fundamentals, high growth potential, and fair valuation, with a "Buy" rating from multiple analysts and a target price of $28.22. The company, a late-stage biotechnology firm, is advancing therapies for retinal vascular diseases …

Form S-1 Moleculin Biotech Inc For: 29 July By Investing.com

This article announces the filing of Form S-1 by Moleculin Biotech Inc. on July 29. It briefly lists the company's stock symbol MBRX and its current performance percentage. The article is very short and serves primarily as a notification of the filing.

Colgate-Palmolive Company $CL Shares Sold by Hilltop Holdings Inc.

Hilltop Holdings Inc. significantly reduced its stake in Colgate-Palmolive Company by 89.2% in the first quarter, selling 26,837 shares and valuing its remaining holdings at $277,000. While some institutional investors increased their positions, analysts generally maintain a "Moderate Buy" rating for Colgate-Palmolive with an …